These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35026004)

  • 21. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
    Petersen LC
    Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urokinase mediates fibrinolysis in the pulmonary microvasculature.
    Bdeir K; Murciano JC; Tomaszewski J; Koniaris L; Martinez J; Cines DB; Muzykantov VR; Higazi AA
    Blood; 2000 Sep; 96(5):1820-6. PubMed ID: 10961882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFI.
    Mutch NJ; Moore NR; Wang E; Booth NA
    J Thromb Haemost; 2003 Sep; 1(9):2000-7. PubMed ID: 12941043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.
    Hisada Y; Ay C; Auriemma AC; Cooley BC; Mackman N
    J Thromb Haemost; 2017 Nov; 15(11):2208-2217. PubMed ID: 28834179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. uPA-mediated plasminogen activation is enhanced by polyphosphate.
    Whyte CS; Mutch NJ
    Haematologica; 2021 Feb; 106(2):522-531. PubMed ID: 32029503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of plasminogen activator inhibitor-1 (PAI-1) by the naphthoquinone shikonin.
    Han T; Zhang G; Yan D; Yang H; Ma T; Ye Z
    Fitoterapia; 2016 Sep; 113():117-22. PubMed ID: 27476618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
    Festuccia C; Dolo V; Guerra F; Violini S; Muzi P; Pavan A; Bologna M
    Clin Exp Metastasis; 1998 Aug; 16(6):513-28. PubMed ID: 9872599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinolytic changes in a patient with toxic shock syndrome; release of active u-PA.
    Haj MA; Robbie LA; Croll A; Adey GD; Bennett B
    Intensive Care Med; 1998 Mar; 24(3):258-61. PubMed ID: 9565810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution.
    Gossage JA; Humphries J; Modarai B; Burnand KG; Smith A
    J Vasc Surg; 2006 Nov; 44(5):1085-90. PubMed ID: 17098546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria.
    Rønne E; Pappot H; Grøndahl-Hansen J; Høyer-Hansen G; Plesner T; Hansen NE; Danø K
    Br J Haematol; 1995 Mar; 89(3):576-81. PubMed ID: 7734357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes.
    Del Rosso A; Cinelli M; Guiducci S; Pignone A; Fibbi G; Margheri F; Gabrielli A; Giacomelli R; Coppini A; Del Rosso M; Matucci Cerinic M
    Rheumatology (Oxford); 2005 Oct; 44(10):1255-62. PubMed ID: 15998634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1.
    Whyte CS; Simpson M; Morrow GB; Wallace CA; Mentzer AJ; Knight JC; Shapiro S; Curry N; Bagot CN; Watson H; Cooper JG; Mutch NJ
    J Thromb Haemost; 2022 Oct; 20(10):2394-2406. PubMed ID: 35780481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.
    Gong L; Proulle V; Fang C; Hong Z; Lin Z; Liu M; Xue G; Yuan C; Lin L; Furie B; Flaumenhaft R; Andreasen P; Furie B; Huang M
    J Cell Mol Med; 2016 Oct; 20(10):1851-60. PubMed ID: 27197780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human tumor cell urokinase-type plasminogen activator (uPA): degradation of the proenzyme form (pro-uPA) by granulocyte elastase prevents subsequent activation by plasmin.
    Schmitt M; Kanayama N; Jänicke F; Hafter R; Graeff H
    Adv Exp Med Biol; 1991; 297():111-28. PubMed ID: 1837419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
    Liu JW; Wei DZ; Du CB; Zhong JJ
    Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
    Sugiyama N; Iwamoto M; Abiko Y
    Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the time to attain maximal clot amplitude after reaching maximal clot formation velocity parameter as a measure of fibrinolysis using rotational thromboelastometry and its application in the assessment of fibrinolytic resistance in septic patients: a prospective observational study: communication from the ISTH SSC Subcommittee on Fibrinolysis.
    Scarlatescu E; Kim PY; Marchenko SP; Tomescu DR
    J Thromb Haemost; 2024 Apr; 22(4):1223-1235. PubMed ID: 38104723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinolysis: the key to new pathogenetic mechanisms.
    Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
    Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms.
    Fontaine V; Jacob MP; Houard X; Rossignol P; Plissonnier D; Angles-Cano E; Michel JB
    Am J Pathol; 2002 Nov; 161(5):1701-10. PubMed ID: 12414517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
    Plesner T; Behrendt N; Ploug M
    Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.